Table 2_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.docx by Marisa R. Young (7919255)

“…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”

Image 2_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

“…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”

Image 11_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

“…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”

Image 7_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

“…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”

Image 8_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

“…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”

Image 6_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

“…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”

Image 4_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

“…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”

Image 9_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

“…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”

Image 12_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

“…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”

Image 1_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.jpeg by Marisa R. Young (7919255)

“…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”

Table 3_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.docx by Marisa R. Young (7919255)

“…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”

Image 13_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

“…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”

Table 1_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.docx by Marisa R. Young (7919255)

“…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”

Image 10_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

“…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”

Image 5_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

“…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”

Association of COL4A2 indel polymorphism with the development of stomach adenocarcinoma in Chinese populations by Huihai Shi (19754499)

“…Then, based on an analysis of patient tumor RNA seq data available from the Cancer Genome Atlas (TCGA), we assessed the prognostic value of mRNA expression of the <i>COL4A2</i> gene in STAD patients using K–M plotter.…”

The minimal data set. by Wenya Zhu (13957497)

“…<div><p><i>Trichogramma ostriniae</i> is one of the most successfully used natural enemies in the integrated management of agroforestry pests. …”

Thymoquinone loaded nanoemulgel in streptozotocin induced diabetic wound by Urati Anuradha (20306190)

“…Further, DIAGEL is obtained by incorporating NE into 1% carbopol^®934. Furthermore, particle size, polydispersity index, thermodynamic stability studies, rheology, spreadability, drug content, <i>in-vitro</i> drug release, <i>ex-vivo</i> permeation, anti-oxidant assay, antimicrobial studies, angioirritance, HAT-CAM assay, <i>in-vitro</i> and <i>in-vivo</i> studies were determined.…”

Baumer-TPW_2023_Dopamine-Monocytes_PMID37251548.xlsx by Tiffany Powell-Wiley (18098425)

“…Indicative of D2-signaling, cAMP levels were found to be lower in DA-treated monocytes compared to</p><p dir="ltr">untreated controls (control 29.78 pmol/ml vs DA 22.97 pmol/ml; p =0.038) and the impact of DA on NCM CCR2</p><p dir="ltr">expression was abrogated by co-treatment with 8-CPT, a cAMP analog. Furthermore, Filamin A (FLNA), a</p><p dir="ltr">prominent actin-crosslinking protein, that is known to regulate CCR2 recycling, significantly decreased in DA-</p><p dir="ltr">treated NCM (p < 0.05), indicating a reduction of CCR2 recycling. …”

Table 1_Association between combined urinary phthalate metabolites exposure and grip strength among residents in Guangzhou, China.docx by Jinbin Chen (4468570)

“…To assess these relationships, we conducted generalized linear regression models, Bayesian Kernel Machine Regression (BKMR), and Weighted Quantile Sum (WQS) regression analyses.…”